Psychological Treatment of Comorbid Insomnia and Depression: A Double-Blind Randomized Placebo-Controlled Trial
Psychotherapy and Psychosomatics · 2024 · 93 (2) · 100-113
DOI: 10.1159/000536063 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Psychotherapy and Psychosomatics, online erschienen am 29.01.2024. Verfasst von Kerstin Blom und 5 weiteren Autor:innen. Beteiligte Einrichtung: Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Stock…. Hauptthemen laut MEDLINE: Sleep Initiation and Maintenance Disorders, Major Depressive Disorder. Die Arbeit wurde bisher 45-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Themen: Depression, Schlaf
Abstract (Originalsprache)
Introduction
Insomnia and depression are highly prevalent disorders and commonly occur together. Cognitive behavioral therapy for insomnia, CBT-I, has been shown to be effective in treating insomnia and also comorbid depression. However, it is unclear whether effects of CBT-I on depression are specific or nonspecific. Also, depressive symptoms often remain too high after CBT-I, indicating a need for improved treatments. The objective was to determine whether combining CBT-I with CBT for depression, without increasing treatment length, reduces both insomnia and depression more than CBT for depression with a placebo insomnia intervention.
Methods
A 12-week double-blind randomized controlled trial with a 6-month follow-up in a psychiatric setting using therapist-guided internet-delivered treatments was conducted. Patients (N = 126) were diagnosed with insomnia disorder and major depression by physicians. Primary outcome measures were as follows: self-rating scales Insomnia Severity Index (ISI) and Montgomery-Åsberg Depression Rating Scale (MADRS-S).
Results
The combined treatment showed specific effects on insomnia severity over the control treatment (p = 0.007) but was not more effective in reducing depression severity. Within-group effects (Cohen’s d) at post and at 6 months were as follows: ISI 1.40 and 1.42 (combined treatment), 0.95 and 1.00 (control); MADRS-S 0.97 and 1.12 (combined), 0.88 and 0.89 (control).
Conclusions
CBT-I shows large specific effects on insomnia severity and is superior to control in this regard. Both treatments had similar effects on depression severity, i.e., combining CBT-I with CBT for depression did not enhance outcomes on depression compared to control. We suggest CBT-I should always be offered to patients with insomnia and depression comorbidity, possibly as the first-hand choice. Combining it with a psychological treatment for depression could be too burdening and may not be beneficial.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Centre for Psychiatry Research, Department of Clinical Neuroscience, Karolinska Institutet, & Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
- Stockholm Health Care Services, Region Stockholm, Stockholm, Sweden.
- Division of Psychology, Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
- Department of Psychology, Faculty of Health and Life Sciences, Linnaeus University, Växjö, Sweden.
Zitieren
APA
Blom, K., Forsell, E., Hellberg, M., Svanborg, C., Jernelöv, S., & Kaldo, V. (2024). Psychological Treatment of Comorbid Insomnia and Depression: A Double-Blind Randomized Placebo-Controlled Trial. Psychotherapy and Psychosomatics, 93(2), 100-113. https://doi.org/10.1159/000536063
Vancouver
Blom K, Forsell E, Hellberg M, Svanborg C, Jernelöv S, Kaldo V. Psychological Treatment of Comorbid Insomnia and Depression: A Double-Blind Randomized Placebo-Controlled Trial. Psychotherapy and Psychosomatics. 2024;93(2):100-113. doi:10.1159/000536063
BibTeX
@article{Blom2024,
author = {Blom, Kerstin and Forsell, Erik and Hellberg, Monica and Svanborg, Cecilia and Jernelöv, Susanna and Kaldo, Viktor},
title = {Psychological Treatment of Comorbid Insomnia and Depression: A Double-Blind Randomized Placebo-Controlled Trial},
journal = {Psychotherapy and Psychosomatics},
year = {2024},
volume = {93},
number = {2},
pages = {100--113},
doi = {10.1159/000536063}
}
EUVIMED